Oncternal Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Oncternal Therapeutics shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Oncternal Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Oncternal Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Oncternal Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $29k | 54k | 0.54 |
| 2023-06-30 | $3.7k | 11k | 0.35 |
| 2023-03-31 | $10k | 13k | 0.79 |
| 2022-12-31 | $18k | 18k | 1.00 |
| 2022-06-30 | $1.3M | 1.2M | 1.11 |
| 2022-03-31 | $309k | 224k | 1.38 |
| 2021-12-31 | $313k | 138k | 2.27 |
| 2021-09-30 | $1.1M | 258k | 4.16 |
| 2021-06-30 | $1.1M | 235k | 4.76 |
| 2021-03-31 | $2.6M | 315k | 8.32 |
| 2020-12-31 | $170k | 34k | 4.93 |